Related Experiment Video
Updated: Apr 28, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
13.2K
Group A streptococcus inhibitors by high-throughput virtual screening.
Haipeng Hu1, Shuli Mao1, Julia V Bugrysheva2
1Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, GA 30322, USA.
European Journal of Medicinal Chemistry
|June 2, 2014
Summary
Researchers identified potential inhibitors for Group A Streptococcus (GAS) growth by targeting essential RNase J1/J2 enzymes. Homology modeling and virtual screening led to the discovery of two compounds showing promising antimicrobial activity.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- Group A Streptococcus (GAS) causes a spectrum of diseases, from mild to life-threatening.
- RNase J1 and J2 enzymes are recently identified as essential for GAS viability and growth.
Purpose of the Study:
- To identify novel inhibitors targeting RNase J1/J2 enzymes in GAS.
- To develop potential therapeutic strategies against GAS infections.
Main Methods:
- Construction of homology models for ligand-free (apo) and ligand-bound (holo) forms of RNase J1/J2.
- High-throughput virtual screening (HTVS) using focused small molecule libraries and the Maybridge database.
- Cell-based biological assays to evaluate inhibitor efficacy.
Main Results:
- Two compounds were identified as potential inhibitors of RNase J1/J2.
- These compounds demonstrated Minimum Inhibitory Concentration (MIC) activity at 10 μM in cell-based assays.
Conclusions:
- The study successfully identified novel compounds targeting essential GAS enzymes.
- These findings provide a foundation for developing new anti-GAS therapeutics.
